257 related articles for article (PubMed ID: 25362986)
1. Chemotherapy drug extravasation in totally implantable venous access port systems: how effective is early surgical lavage?
Azaïs H; Bresson L; Bassil A; Katdare N; Merlot B; Houpeau JL; El Bedoui S; Meurant JP; Tresch E; Narducci F
J Vasc Access; 2015; 16(1):31-7. PubMed ID: 25362986
[TBL] [Abstract][Full Text] [Related]
2. Managing chemotherapy extravasation in totally implantable central venous access: Use of subcutaneous wash-out technique.
Taibi A; Bardet M S; Durand Fontanier S; Deluche E; Fredon F; Christou N; Usseglio J; Mathonnet M
J Vasc Access; 2020 Sep; 21(5):723-731. PubMed ID: 32056485
[TBL] [Abstract][Full Text] [Related]
3. [Extravasation of cytostatics. Example of a severe complication from the use of long-term central venous catheters].
Bach F; Videbaek C; Holst-Christensen J; Boesby S
Ugeskr Laeger; 1991 Oct; 153(41):2896-7. PubMed ID: 1949309
[TBL] [Abstract][Full Text] [Related]
4. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy drug extravasation in totally implantable venous access port systems: use of subcutaneous wash-out technique (with vidéo)].
Taibi A; Ferrero PA; Derbal S
Gynecol Obstet Fertil Senol; 2020 Apr; 48(4):398-399. PubMed ID: 31991173
[No Abstract] [Full Text] [Related]
6. A comparison of infections and complications in central venous catheters in adults with solid tumours.
Coady K; Ali M; Sidloff D; Kenningham RR; Ahmed S
J Vasc Access; 2015; 16(1):38-41. PubMed ID: 25198809
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy extravasation: a consequence of fibrin sheath formation around venous access devices.
Mayo DJ; Pearson DC
Oncol Nurs Forum; 1995 May; 22(4):675-80. PubMed ID: 7675669
[TBL] [Abstract][Full Text] [Related]
8. Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre.
Narducci F; Jean-Laurent M; Boulanger L; El Bédoui S; Mallet Y; Houpeau JL; Hamdani A; Penel N; Fournier C
Eur J Surg Oncol; 2011 Oct; 37(10):913-8. PubMed ID: 21831566
[TBL] [Abstract][Full Text] [Related]
9. Innominate vein stenosis in breast cancer patients after totally implantable venous access port placement.
Song MG; Seo TS; Kang EY; Yong HS; Seo JH; Choi YY
J Vasc Access; 2015; 16(4):315-20. PubMed ID: 25953212
[TBL] [Abstract][Full Text] [Related]
10. Totally implantable venous-access ports: local problems and extravasation injury.
Kurul S; Saip P; Aydin T
Lancet Oncol; 2002 Nov; 3(11):684-92. PubMed ID: 12424071
[TBL] [Abstract][Full Text] [Related]
11. Mediastinal extravasation of doxorubicin.
Quintanar Verdúguez T; Blanco Jarava A; Martínez-Barbeito MB; Pangua Méndez C; López Gómez L; Andrade Santiago J; Chacón López-Muñiz I
Clin Transl Oncol; 2008 Feb; 10(2):128-30. PubMed ID: 18258513
[TBL] [Abstract][Full Text] [Related]
12. Safe use of power injectors with central and peripheral venous access devices for pediatric CT.
Kaste SC; Young CW
Pediatr Radiol; 1996; 26(8):499-501. PubMed ID: 8753658
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy extravasation from implanted ports.
Schulmeister L; Camp-Sorrell D
Oncol Nurs Forum; 2000 Apr; 27(3):531-8; quiz 539-40. PubMed ID: 10785905
[TBL] [Abstract][Full Text] [Related]
14. Iatrogenic chylothorax due to pleural cavity extravasation of total parenteral nutrition in two adults receiving nutrition through a peripherally inserted central catheter.
Johnson TJ; Jamous FG; Kooistra A; Zawada ET
Hosp Pract (1995); 2010 Feb; 38(1):50-2. PubMed ID: 20469624
[TBL] [Abstract][Full Text] [Related]
15. Venous port systems in the field of gynaecological oncology.
Rauthe G; Altmann C
Eur J Gynaecol Oncol; 1998; 19(2):173-8. PubMed ID: 9611061
[TBL] [Abstract][Full Text] [Related]
16. IR Approaches to Difficult Removals of Totally Implanted Venous Access Port Catheters in Children: A Single-Center Experience.
Patel PA; Parra DA; Bath R; Amaral JG; Temple MJ; John PR; Connolly BL
J Vasc Interv Radiol; 2016 Jun; 27(6):876-81. PubMed ID: 27106735
[TBL] [Abstract][Full Text] [Related]
17. Severe Neutropenia at the Time of Implantable Subcutaneous Chest Port Insertion Is Not a Risk Factor for Port Removal at a Tertiary Pediatric Center.
Hoss DR; Bedros AA; Mesipam A; Criddle J; Smith JC
J Vasc Interv Radiol; 2017 Mar; 28(3):398-402. PubMed ID: 28034702
[TBL] [Abstract][Full Text] [Related]
18. Cardiac tamponade and bilateral pleural effusion in a very low birth weight infant.
Haass C; Sorrentino E; Tempera A; Consigli C; De Paola D; Calcagni G; Piastra M; Finocchi M
J Matern Fetal Neonatal Med; 2009 Feb; 22(2):137-9. PubMed ID: 19253161
[TBL] [Abstract][Full Text] [Related]
19. Fractures of totally implantable central venous ports: more than fortuity. A three-year single center experience.
Balsorano P; Galducci G; De Fanti I; Evans SK; De Gaudio AR; Pelagatti C
J Vasc Access; 2014; 15(5):391-5. PubMed ID: 25041921
[TBL] [Abstract][Full Text] [Related]
20. Mode of chemotherapy does not affect complications with an implantable venous access device.
Brown DF; Muirhead MJ; Travis PM; Vire SR; Weller J; Hauer-Jensen M
Cancer; 1997 Sep; 80(5):966-72. PubMed ID: 9307199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
